Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Emergency Service, Hospital | 9 | 2018 | 221 | 1.500 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 6 | 2018 | 13 | 1.490 |
Why?
|
| Pulmonary Embolism | 6 | 2011 | 59 | 0.920 |
Why?
|
| Fibrinolytic Agents | 3 | 2018 | 56 | 0.730 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 37 | 0.630 |
Why?
|
| Colonoscopy | 3 | 2020 | 51 | 0.620 |
Why?
|
| Emergency Medicine | 4 | 2015 | 79 | 0.580 |
Why?
|
| Medical Overuse | 1 | 2015 | 6 | 0.550 |
Why?
|
| Health Policy | 1 | 2015 | 50 | 0.530 |
Why?
|
| Duodenal Diseases | 1 | 2013 | 6 | 0.470 |
Why?
|
| Vascular Fistula | 1 | 2013 | 4 | 0.470 |
Why?
|
| Intestinal Fistula | 1 | 2013 | 7 | 0.470 |
Why?
|
| Abdominal Pain | 1 | 2013 | 9 | 0.470 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 10 | 0.470 |
Why?
|
| Enema | 1 | 2010 | 3 | 0.380 |
Why?
|
| Polyethylene Glycols | 1 | 2010 | 55 | 0.360 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 79 | 0.340 |
Why?
|
| Critical Pathways | 1 | 2007 | 21 | 0.310 |
Why?
|
| Ischemic Attack, Transient | 1 | 2007 | 20 | 0.310 |
Why?
|
| Enterobius | 1 | 2006 | 1 | 0.290 |
Why?
|
| Enterobiasis | 1 | 2006 | 1 | 0.290 |
Why?
|
| Cecum | 1 | 2006 | 7 | 0.290 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2005 | 130 | 0.280 |
Why?
|
| Humans | 21 | 2020 | 29337 | 0.250 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 333 | 0.210 |
Why?
|
| Sensitivity and Specificity | 6 | 2009 | 553 | 0.210 |
Why?
|
| Health Services Research | 3 | 2015 | 41 | 0.190 |
Why?
|
| Endoscopy, Digestive System | 1 | 2020 | 9 | 0.190 |
Why?
|
| Gastroenterology | 1 | 2020 | 11 | 0.180 |
Why?
|
| Decision Support Techniques | 2 | 2018 | 52 | 0.180 |
Why?
|
| Age Factors | 3 | 2018 | 843 | 0.170 |
Why?
|
| Telephone | 1 | 1997 | 27 | 0.160 |
Why?
|
| Aftercare | 1 | 1997 | 22 | 0.160 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 77 | 0.160 |
Why?
|
| Continuity of Patient Care | 1 | 1997 | 28 | 0.160 |
Why?
|
| Knowledge | 2 | 2007 | 19 | 0.160 |
Why?
|
| Male | 10 | 2020 | 15621 | 0.150 |
Why?
|
| Diffusion of Innovation | 2 | 2007 | 38 | 0.150 |
Why?
|
| Feasibility Studies | 3 | 2020 | 227 | 0.150 |
Why?
|
| Adult | 5 | 2018 | 8601 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2015 | 36 | 0.140 |
Why?
|
| Environment | 1 | 2015 | 46 | 0.130 |
Why?
|
| Aged | 6 | 2013 | 9448 | 0.130 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 62 | 0.130 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 90 | 0.130 |
Why?
|
| Time Factors | 2 | 2015 | 1616 | 0.130 |
Why?
|
| Risk Factors | 3 | 2018 | 2443 | 0.130 |
Why?
|
| Risk Assessment | 3 | 2008 | 679 | 0.120 |
Why?
|
| Middle Aged | 7 | 2012 | 9823 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2013 | 770 | 0.120 |
Why?
|
| Patient Care Team | 1 | 2015 | 140 | 0.120 |
Why?
|
| Prospective Studies | 4 | 2020 | 1811 | 0.120 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2013 | 10 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 389 | 0.100 |
Why?
|
| Headache | 1 | 2012 | 43 | 0.100 |
Why?
|
| Medicare | 1 | 2012 | 121 | 0.100 |
Why?
|
| Female | 8 | 2020 | 16197 | 0.100 |
Why?
|
| Colonic Diseases | 1 | 2010 | 12 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 223 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 437 | 0.090 |
Why?
|
| Resuscitation | 1 | 2008 | 18 | 0.080 |
Why?
|
| Antifibrinolytic Agents | 1 | 2009 | 23 | 0.080 |
Why?
|
| Cause of Death | 1 | 2008 | 65 | 0.080 |
Why?
|
| Program Evaluation | 2 | 2020 | 132 | 0.080 |
Why?
|
| Lower Extremity | 1 | 2008 | 38 | 0.080 |
Why?
|
| Information Dissemination | 1 | 2007 | 23 | 0.080 |
Why?
|
| Hospital Mortality | 1 | 2008 | 141 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2008 | 42 | 0.080 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2007 | 10 | 0.080 |
Why?
|
| Protein Precursors | 1 | 2006 | 19 | 0.070 |
Why?
|
| Calcitonin | 1 | 2006 | 15 | 0.070 |
Why?
|
| Sepsis | 1 | 2008 | 144 | 0.070 |
Why?
|
| ROC Curve | 2 | 2008 | 138 | 0.070 |
Why?
|
| Recurrence | 1 | 2007 | 350 | 0.070 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2005 | 5 | 0.070 |
Why?
|
| Heparin | 1 | 2005 | 26 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2007 | 394 | 0.070 |
Why?
|
| Bacteremia | 1 | 2006 | 115 | 0.070 |
Why?
|
| Pulmonary Artery | 1 | 2005 | 43 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 96 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2005 | 96 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2005 | 340 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 1184 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2005 | 67 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2007 | 211 | 0.060 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2003 | 1 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2010 | 3478 | 0.060 |
Why?
|
| Stroke | 1 | 2007 | 293 | 0.060 |
Why?
|
| Critical Illness | 1 | 2005 | 123 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 521 | 0.060 |
Why?
|
| Ambulatory Care | 1 | 2003 | 75 | 0.060 |
Why?
|
| Clinical Competence | 2 | 2020 | 230 | 0.060 |
Why?
|
| Learning Curve | 1 | 2020 | 18 | 0.050 |
Why?
|
| Accreditation | 1 | 2020 | 16 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2005 | 1939 | 0.040 |
Why?
|
| Peptic Ulcer | 1 | 1998 | 6 | 0.040 |
Why?
|
| Michigan | 1 | 1997 | 16 | 0.040 |
Why?
|
| Hospitals, Community | 1 | 1997 | 14 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 1997 | 33 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 4851 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 107 | 0.040 |
Why?
|
| Animals | 1 | 2006 | 4552 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 1997 | 162 | 0.040 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2015 | 4 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2015 | 34 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 1997 | 295 | 0.030 |
Why?
|
| Communication | 1 | 2015 | 111 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 1997 | 501 | 0.030 |
Why?
|
| United States | 2 | 2012 | 2333 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2012 | 136 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 2011 | 56 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 788 | 0.020 |
Why?
|
| Angiography | 1 | 2009 | 38 | 0.020 |
Why?
|
| Observer Variation | 1 | 2008 | 118 | 0.020 |
Why?
|
| Shock, Septic | 1 | 2008 | 62 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2008 | 298 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 142 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2006 | 15 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 340 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2007 | 81 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2008 | 226 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 208 | 0.020 |
Why?
|
| Critical Care | 1 | 2008 | 234 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2006 | 285 | 0.020 |
Why?
|
| Prevalence | 1 | 2006 | 487 | 0.020 |
Why?
|
| Survival Rate | 1 | 2005 | 349 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1113 | 0.020 |
Why?
|
| Radiography | 1 | 2005 | 678 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2012 | 3273 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 1932 | 0.010 |
Why?
|
| Child | 1 | 2006 | 1346 | 0.010 |
Why?
|
| Brain | 1 | 2012 | 1689 | 0.010 |
Why?
|